The story of Viagra presents a complex case for investors in the medicinal sector. While initially a blockbuster success, creating huge profits, the exclusivity lapse and the subsequent flood of off-brand versions have https://pharma858825.theisblog.com/42195526/sildenafil-and-big-pharma-a-risky-investment